Covington & Burling represented uniQure in the transaction. uniQure N.V. (NASDAQ: QURE), a leading gene therapy company, announced the closing of the sale of its global...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised uniQure N.V. on the deal. uniQure N.V. signed an agreement to sell a portion of the royalty rights due to uniQure from biopharmaceutical...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery has advised Corlieve Therapeutics, while Morgan Lewis has advised uniQure on the deal. Corlieve Therapeutics completed its sale to uniQure, with its...
You must be a Standard 1 Year member to access this content.
